These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26280346)

  • 1. Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.
    You Y; Zheng Q; Dong Y; Wang Y; Zhang L; Xue T; Xie X; Hu C; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    PLoS One; 2015; 10(8):e0134243. PubMed ID: 26280346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1.
    Dong Y; Xie X; Wang Z; Hu C; Zheng Q; Wang Y; Chen R; Xue T; Chen J; Gao D; Wu W; Ren Z; Cui J
    Biochem Biophys Res Commun; 2014 Feb; 444(3):427-32. PubMed ID: 24472554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate stiffness promotes latent TGF-β1 activation in hepatocellular carcinoma.
    Pang M; Teng Y; Huang J; Yuan Y; Lin F; Xiong C
    Biochem Biophys Res Commun; 2017 Jan; 483(1):553-558. PubMed ID: 28025149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.
    Iqbal J; McRae S; Banaudha K; Mai T; Waris G
    J Biol Chem; 2013 Dec; 288(52):36994-7009. PubMed ID: 24240095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.
    Mitra A; Menezes ME; Pannell LK; Mulekar MS; Honkanen RE; Shevde LA; Samant RS
    Oncogene; 2012 Oct; 31(41):4472-83. PubMed ID: 22266849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment.
    Park SY; Lee YK; Kim HJ; Park OJ; Kim YM
    Oncol Rep; 2016 Mar; 35(3):1566-72. PubMed ID: 26707164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.
    Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K
    Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
    Jiang J; Xu B; Zheng Y; Guo X; Chen F
    Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
    Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
    J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma.
    Wang XH; Meng XW; Xing H; Qu B; Han MZ; Chen J; Fan YJ; Lu CQ; Lu ZW
    Hepatogastroenterology; 2011; 58(106):487-91. PubMed ID: 21661417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma.
    Ban KC; Singh H; Krishnan R; Seow HF
    Cancer Lett; 2003 Sep; 199(2):201-8. PubMed ID: 12969793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
    Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
    Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
    Wu S; Zheng Q; Xing X; Dong Y; Wang Y; You Y; Chen R; Hu C; Chen J; Gao D; Zhao Y; Wang Z; Xue T; Ren Z; Cui J
    J Exp Clin Cancer Res; 2018 May; 37(1):99. PubMed ID: 29728125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
    Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway.
    Wang C; Cao F; Cao J; Jiao Z; You Y; Xiong Y; Zhao W; Wang X
    J Transl Med; 2023 Aug; 21(1):539. PubMed ID: 37573318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.